REPL vs SHW · $825.7M cap vs P/E 29, rev $23.10B
Replimune Group Inc (REPL) versus Sherwin-Williams Co (SHW) — a side-by-side from cached financials, not a winner call.
Replimune Group Inc (REPL) is a biotechnology company listed on NASDAQ.
Sherwin-Williams Co (SHW) is a specialty chemicals company listed on US.
REPL does not have a complete income-statement cache yet.
Latest reported SHW revenue for 2024-12-31 was $23.10B. Net income was $2.68B. Revenue was up 0.2% from 2023-12-31 to 2024-12-31. SHW currently screens at market cap $75.30B and trailing P/E 29.3.
REPL currently screens at market cap $825.7M. SHW currently screens at market cap $75.30B and trailing P/E 29.3.
Not investment advice. Open the REPL and SHW stock pages for the full models.
Not investment advice.